ABT Stock Price, Chart, Stats & News

ABT chart
Fundamentals
Gross margin | 55.51% |
Operating margin | 18.16% |
Pretax margin | 19.10% |
Net margin | 14.72% |
Effective tax rate | 22.94% |
ROA | 7.52% |
ROE | 12.89% |
D/E | 0.29x |
Interest coverage ratio | 23.60x |
ABT valuation
P/E | 17.46x |
P/S | 4.08x |
P/B | 3.48x |
P/CF | 18.99x |
P/FCF | 24.43x |
P/OCF | 18.99x |
PEG | -0.52x |
EV multiple | 14.97x |
About
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine.
Similar securities
Based on sector and market capitalization










